These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37464369)

  • 1. Failure of diltiazem to prevent 1:1 conduction of atrial flutter: a case report.
    Tiver KD; Martin DK; Quah J; Lahiri A; Ganesan AN
    J Med Case Rep; 2023 Jul; 17(1):319. PubMed ID: 37464369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of paroxysmal atrial flutter that occurred in an outpatient prior to dental surgery: a case report.
    Shimoda H; Takahashi T
    BMC Oral Health; 2019 Dec; 19(1):271. PubMed ID: 31801491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical Cardioversion.
    Colangelo T; Johnson D; Ho R
    Tex Heart Inst J; 2021 Jun; 48(2):. PubMed ID: 34086956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1:1 atrial flutter induced by flecainide, whilst the patient was at rest.
    Comelli I; Pigna F; Cervellin G
    Am J Emerg Med; 2018 Nov; 36(11):2131.e3-2131.e5. PubMed ID: 30033133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation.
    Stabile G; De Simone A; Turco P; La Rocca V; Nocerino P; Astarita C; Maresca F; De Matteis C; Di Napoli T; Stabile E; Vitale DF
    J Am Coll Cardiol; 2001 May; 37(6):1639-44. PubMed ID: 11345378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxysmal Atrial Fibrillation on Flecainide Therapy.
    Gavin JL; Peigh GS; Kim SS
    Eur J Intern Med; 2020 Nov; 81():89-90. PubMed ID: 32980218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of diltiazem in supraventricular paroxysmal tachyarrhythmias].
    De Rosa F; Feraco E; Venneri N; Boncompagni F; Curia F; Guzzo D; Plastina F
    G Ital Cardiol; 1986 Sep; 16(9):776-81. PubMed ID: 3803800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E; Denjoy I
    Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide.
    Taylor R; Gandhi MM; Lloyd G
    BMJ; 2010 Mar; 340():b4684. PubMed ID: 20219811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs.
    Kawabata M; Hirao K; Horikawa T; Suzuki K; Motokawa K; Suzuki F; Azegami K; Hiejima K
    J Electrocardiol; 2001 Jan; 34(1):65-72. PubMed ID: 11239374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug.
    Crijns HJ; Van Gelder IC; Kingma JH; Dunselman PH; Gosselink AT; Lie KI
    Eur Heart J; 1994 Oct; 15(10):1403-8. PubMed ID: 7821320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical case of the month. Atrial flutter with rapid ventricular response (1:1 atrioventricular conduction) caused by flecaïnide].
    Robinet S; Melon R; Piérard L
    Rev Med Liege; 2007 Dec; 62(12):701-3. PubMed ID: 18286943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1:1 atrioventricular conduction in atrial flutter with digoxin and flecainide.
    Ahsan A; Aldridge R; Bowes R
    Int J Cardiol; 1993 Apr; 39(1):88-90. PubMed ID: 8407013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ; Kingma JH; Jessurun ER; Lie-A-Huen L; van Hemel NM; Lie KI
    J Am Coll Cardiol; 1990 Dec; 16(7):1722-7. PubMed ID: 2123909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ
    Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
    Naccarelli GV; Dorian P; Hohnloser SH; Coumel P
    Am J Cardiol; 1996 Jan; 77(3):53A-59A. PubMed ID: 8607392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department.
    Fromm C; Suau SJ; Cohen V; Likourezos A; Jellinek-Cohen S; Rose J; Marshall J
    J Emerg Med; 2015 Aug; 49(2):175-82. PubMed ID: 25913166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wide complex tachycardia in the presence of class I antiarrhythmic agents: a diagnostic challenge.
    Bhardwaj B; Lazzara R; Stavrakis S
    Ann Noninvasive Electrocardiol; 2014 May; 19(3):289-92. PubMed ID: 24112534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac devices with class 1C antiarrhythmics: a potentially toxic combination.
    Apps A; Miller CP; Fellows S; Jones M
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26286909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.